1. Home
  2. AREN vs CRVS Comparison

AREN vs CRVS Comparison

Compare AREN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • CRVS
  • Stock Information
  • Founded
  • AREN 2016
  • CRVS 2014
  • Country
  • AREN United States
  • CRVS United States
  • Employees
  • AREN N/A
  • CRVS N/A
  • Industry
  • AREN Medical/Dental Instruments
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • CRVS Health Care
  • Exchange
  • AREN Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • AREN 305.8M
  • CRVS 305.4M
  • IPO Year
  • AREN N/A
  • CRVS 2016
  • Fundamental
  • Price
  • AREN $5.90
  • CRVS $5.75
  • Analyst Decision
  • AREN Strong Buy
  • CRVS Strong Buy
  • Analyst Count
  • AREN 1
  • CRVS 4
  • Target Price
  • AREN $12.00
  • CRVS $15.00
  • AVG Volume (30 Days)
  • AREN 243.8K
  • CRVS 518.7K
  • Earning Date
  • AREN 08-14-2025
  • CRVS 08-07-2025
  • Dividend Yield
  • AREN N/A
  • CRVS N/A
  • EPS Growth
  • AREN N/A
  • CRVS N/A
  • EPS
  • AREN 2.74
  • CRVS N/A
  • Revenue
  • AREN $146,610,000.00
  • CRVS N/A
  • Revenue This Year
  • AREN $29.48
  • CRVS N/A
  • Revenue Next Year
  • AREN $11.72
  • CRVS N/A
  • P/E Ratio
  • AREN $9.36
  • CRVS N/A
  • Revenue Growth
  • AREN 6.81
  • CRVS N/A
  • 52 Week Low
  • AREN $0.56
  • CRVS $2.54
  • 52 Week High
  • AREN $10.05
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • AREN 41.23
  • CRVS 65.10
  • Support Level
  • AREN $6.09
  • CRVS $5.28
  • Resistance Level
  • AREN $7.00
  • CRVS $5.64
  • Average True Range (ATR)
  • AREN 0.64
  • CRVS 0.30
  • MACD
  • AREN -0.12
  • CRVS 0.03
  • Stochastic Oscillator
  • AREN 1.52
  • CRVS 77.70

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: